Table of Contents

2019-2024 Global Clotrimazole Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Clotrimazole Consumption 2014-2024
  • 2.1.2 Clotrimazole Consumption CAGR by Region
• 2.2 Clotrimazole Segment by Type
  • 2.2.1 Suppository
  • 2.2.2 Tablet
  • 2.2.3 Cream
  • 2.2.4 Others
• 2.3 Clotrimazole Consumption by Type
  • 2.3.1 Global Clotrimazole Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Clotrimazole Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Clotrimazole Sale Price by Type (2014-2019)
• 2.4 Clotrimazole Segment by Application
  • 2.4.1 Vaginitis
  • 2.4.2 Otomycosis
  • 2.4.3 Paronychia
  • 2.4.4 Tinea of Feed and Hands
  • 2.4.5 Tinea Corporis
• 2.5 Clotrimazole Consumption by Application
  • 2.5.1 Global Clotrimazole Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Clotrimazole Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Clotrimazole Sale Price by Application (2014-2019)

3 Global Clotrimazole by Players

• 3.1 Global Clotrimazole Sales Market Share by Players
  • 3.1.1 Global Clotrimazole Sales by Players (2017-2019)
  • 3.1.2 Global Clotrimazole Sales Market Share by Players (2017-2019)
• 3.2 Global Clotrimazole Revenue Market Share by Players
  • 3.2.1 Global Clotrimazole Revenue by Players (2017-2019)
  • 3.2.2 Global Clotrimazole Revenue Market Share by Players (2017-2019)
• 3.3 Global Clotrimazole Sale Price by Players
• 3.4 Global Clotrimazole Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Clotrimazole Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Clotrimazole Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Clotrimazole by Regions

• 4.1 Clotrimazole by Regions
  • 4.1.1 Global Clotrimazole Consumption by Regions
  • 4.1.2 Global Clotrimazole Value by Regions
• 4.2 Americas Clotrimazole Consumption Growth
• 4.3 APAC Clotrimazole Consumption Growth
• 4.4 Europe Clotrimazole Consumption Growth
• 4.5 Middle East & Africa Clotrimazole Consumption Growth

5 Americas

• 5.1 Americas Clotrimazole Consumption by Countries
  • 5.1.1 Americas Clotrimazole Consumption by Countries (2014-2019)
  • 5.1.2 Americas Clotrimazole Value by Countries (2014-2019)
• 5.2 Americas Clotrimazole Consumption by Type
• 5.3 Americas Clotrimazole Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Clotrimazole Consumption by Countries
  • 6.1.1 APAC Clotrimazole Consumption by Countries (2014-2019)
  • 6.1.2 APAC Clotrimazole Value by Countries (2014-2019)
• 6.2 APAC Clotrimazole Consumption by Type
• 6.3 APAC Clotrimazole Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Clotrimazole by Countries
  • 7.1.1 Europe Clotrimazole Consumption by Countries (2014-2019)
  • 7.1.2 Europe Clotrimazole Value by Countries (2014-2019)
• 7.2 Europe Clotrimazole Consumption by Type
• 7.3 Europe Clotrimazole Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Clotrimazole by Countries
  • 8.1.1 Middle East & Africa Clotrimazole Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Clotrimazole Value by Countries (2014-2019)
• 8.2 Middle East & Africa Clotrimazole Consumption by Type
• 8.3 Middle East & Africa Clotrimazole Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Clotrimazole Distributors
• 10.3 Clotrimazole Customer

11 Global Clotrimazole Market Forecast

• 11.1 Global Clotrimazole Consumption Forecast (2019-2024)
• 11.2 Global Clotrimazole Forecast by Regions
  • 11.2.1 Global Clotrimazole Forecast by Regions (2019-2024)
  • 11.2.2 Global Clotrimazole Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Clotrimazole Forecast by Type
• 11.8 Global Clotrimazole Forecast by Application

12 Key Players Analysis

• 12.1 Bayer
  • 12.1.1 Company Details
  • 12.1.2 Clotrimazole Product Offered
  • 12.1.3 Bayer Clotrimazole Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Bayer News
• 12.2 Erregierre
  • 12.2.1 Company Details
  • 12.2.2 Clotrimazole Product Offered
  • 12.2.3 Erregierre Clotrimazole Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Erregierre News
• 12.3 F.I.S.
  • 12.3.1 Company Details
  • 12.3.2 Clotrimazole Product Offered
  • 12.3.3 F.I.S. Clotrimazole Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 F.I.S. News
• 12.4 Amoli Organics
  • 12.4.1 Company Details
  • 12.4.2 Clotrimazole Product Offered
  • 12.4.3 Amoli Organics Clotrimazole Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Amoli Organics News
• 12.5 CordenPharma
  • 12.5.1 Company Details
  • 12.5.2 Clotrimazole Product Offered
  • 12.5.3 CordenPharma Clotrimazole Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 CordenPharma News
• 12.6 Ciron Group
  • 12.6.1 Company Details
  • 12.6.2 Clotrimazole Product Offered
  • 12.6.3 Ciron Group Clotrimazole Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Ciron Group News
• 12.7 Halcyon Labs
  • 12.7.1 Company Details
  • 12.7.2 Clotrimazole Product Offered
  • 12.7.3 Halcyon Labs Clotrimazole Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Halcyon Labs News
• 12.8 INFA Group
  • 12.8.1 Company Details
  • 12.8.2 Clotrimazole Product Offered
  • 12.8.3 INFA Group Clotrimazole Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 INFA Group News
• 12.9 Manus Aktteva
  • 12.9.1 Company Details
  • 12.9.2 Clotrimazole Product Offered
  • 12.9.3 Manus Aktteva Clotrimazole Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 Manus Aktteva News
• 12.10 Guangzhou Hanpu
  • 12.10.1 Company Details
  • 12.10.2 Clotrimazole Product Offered
  • 12.10.3 Guangzhou Hanpu Clotrimazole Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.10.4 Main Business Overview
  • 12.10.5 Guangzhou Hanpu News
• 12.11 Jiangsu Yunyang
• 12.12 Wuhan DKY
• 12.13 Hubei Aoxiang
• 12.14 Jintan Zhongxing

13 Research Findings and Conclusion

Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad-spectrum antimycotic agent effective pathogenic dermophytes, yeasts, Candida, Trichophyton, etc.
China is the largest supplier of clotrimazole, the manufacturers in China have a total capacity of 160 MT. In last years, there are some manufacturers have exist this market due to the environmental policies. China is also a major consumption market with many pharmaceutical companies.
Europe and India are also the major manufacturing bases of clotrimazole. But the manufacturers in these regions generally have a relatively low capacity. Because of the policies about development of APIs in India, the India market will occupy larger share in the market.
The clotrimazole market is relatively stable. But all these manufacturers have low capacity utilization. To maintain the development of clotrimazole industry, manufacturers should develop new technology without environmental issues or find new applications for clotrimazole.

According to this study, over the next five years the Clotrimazole market will register a 1.6% CAGR in terms of revenue, the global market size will reach US$ 5 million by 2024, from US$ 4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Clotrimazole business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Clotrimazole market by product type, application, key manufacturers and key regions and countries.

This study considers the Clotrimazole value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Suppository
Tablet
Cream
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Vaginitis
Otomycosis
Paronychia
Tinea of Feed and Hands
Tinea Corporis

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Erregierre
F.I.S.
Amoli Organics
CordenPharma
Ciron Group
Halcyon Labs
INFA Group
Manus Aktteva
Guangzhou Hanpu
Jiangsu Yunyang
Wuhan DKY
Hubei Aoxiang
Jintan Zhongxing

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Clotrimazole consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Clotrimazole market by identifying its various subsegments.
Focuses on the key global Clotrimazole manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Clotrimazole with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Clotrimazole submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.